Vanessa Carle - 31 Jul 2024 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Reporting relationship
Secretary
Issuer ticker
LEXX
Reported as of
31 Jul 2024
Net transaction value
-$10,268
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Aug 2024, 12:25:52 UTC
Prior SEC filing
15 May 2024
Next SEC filing
16 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/Vanessa Carle/

Key filing fact

Vanessa Carle filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 01 Aug 2024.

Key facts

  • This page summarizes Vanessa Carle's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
  • 1 reported transaction and 7 derivative rows are listed below.
  • Accepted by SEC: 01 Aug 2024, 12:25.

Change

  • Previous filing in this sequence was filed on 15 May 2024.
  • Current net transaction value: -$10,268.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LEXX transaction

common shares

Sale

Transaction value
$10,268
Shares
-2,567
Change %
-100%
Price
$4.00
Shares after
0
Date
31 Jul 2024
Ownership
Direct
LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,567
Date
31 Jul 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LEXX holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
67
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Shares
Underlying amount
67
Exercise price
$36.00
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,567
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Shares
Underlying amount
12,500
Exercise price
$3.00
Footnotes
F1
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
17,567
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Shares
Underlying amount
5,000
Exercise price
$3.00
Footnotes
F2
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
27,567
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Shares
Underlying amount
10,000
Exercise price
$3.00
Footnotes
F3
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
40,067
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Shares
Underlying amount
12,500
Exercise price
$2.91
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
50,067
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Shares
Underlying amount
10,000
Exercise price
$1.15
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
60,067
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Shares
Underlying amount
10,000
Exercise price
$2.36
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Repriced from $5.31 pursuant to shareholder approval received May 9,2023

Footnote F2

Repriced from $7.08 pursuant to shareholder approval received May 9, 2023

Footnote F3

Repriced from $6.23 pursuant to shareholder approval received May 9, 2023

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .